{"id":"W2754153257","doi":"10.1016/j.euf.2017.08.008","title":"Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Allergan; Ferring Pharmaceuticals; Astellas Pharma Europe; Astellas Pharma US; Astellas Pharma; Medtronic; Pfizer","keywords":"Mirabegron; Solifenacin; Medicine; Overactive bladder; Urology; Internal medicine; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001672352,0.0007764073,0.001882268,0.0005416057,0.0003484508,0.0008008685,0.0003564683,0.0004819668,0.001655256],"category_scores_gemma":[0.003362396,0.0003569433,0.004896462,0.001026107,0.0003239562,0.00057139,0.0005879267,0.0007424951,0.0001832921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004737527,"about_ca_system_score_gemma":0.0007339861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001431166,"about_ca_topic_score_gemma":0.004591843,"domain_scores_codex":[0.998446,0.0005114493,0.0002883338,0.0002808641,0.0003109143,0.0001625453],"domain_scores_gemma":[0.9971191,0.0009424255,0.001258332,0.0002046131,0.0002057229,0.0002698143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07877667,0.0006312838,0.8563533,0.001504676,0.02854815,0.000450478,0.0001843191,0.0004196999,0.003656518,0.0001678533,0.0006742349,0.0286328],"study_design_scores_gemma":[0.005447782,0.005199157,0.9662311,0.0002740837,0.0193249,0.0005429311,0.0001639847,0.0003267218,0.0004179385,0.0001058375,0.001915678,0.00004975419],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907058,0.007119821,0.0002793642,0.00007025972,0.00003613251,0.0001131998,0.0008225297,0.000006166129,0.0008467399],"genre_scores_gemma":[0.9965041,0.001525449,0.0002627642,0.000176547,0.00004751096,0.00005867672,0.001265057,0.000005876808,0.0001540191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001882268,"threshold_uncertainty_score":0.008844376,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798864813891451,"score_gpt":0.286416191893726,"score_spread":0.2684275437548115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}